Effects of omalizumab in a patient with three types of chronic urticaria
Author:
Affiliation:
1. Faculdade Evangélica de Medicina do Paraná Paraná Brazil
2. Department of Dermatology and Allergy Charité – Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.12628
Reference8 articles.
1. EAACI/GA 2 LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
2. EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
3. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
4. Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
5. Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New insights into chronic inducible urticaria;Current Allergy and Asthma Reports;2024-07-19
2. Safety of omalizumab in chronic urticaria during pregnancy: a real-life study;Clinical and Experimental Dermatology;2023-11-13
3. Omalizumab in the treatment of various forms of chronic urticaria;Russian Journal of Skin and Venereal Diseases;2023-06-22
4. Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study;International Archives of Allergy and Immunology;2022-12-21
5. Omalizumab as a treatment option for antihistamine-refractory aquagenic urticaria;BMJ Case Reports;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3